149 related articles for article (PubMed ID: 35313514)
1. Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients.
Lin GS; Wang WW; Lin H; Lin RS
J Healthc Eng; 2022; 2022():9367919. PubMed ID: 35313514
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of bevacizumab combined with temozolomide dose-dense regimen on recurrent glioma.
Li J; Huang W; Piao M; Liu Z; Ji S; Xue J; Zhu X
J BUON; 2021; 26(1):145-151. PubMed ID: 33721445
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of early postoperative intensity-modulated radiotherapy combined with Temozolomide chemotherapy in the treatment of patients with malignant glioma.
Zhou H; Wu H; Li M; Dong C; Sun T
Pak J Med Sci; 2022; 38(6):1460-1465. PubMed ID: 35991249
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of thalidomide combined with temozolomide and three-dimensional conformal radiotherapy for patients with high-grade gliomas after operation.
Sui L; Li Y; Xu Z; Shen X
J BUON; 2020; 25(6):2608-2615. PubMed ID: 33455103
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.
Paulino AC; Mazloom A; Terashima K; Su J; Adesina AM; Okcu MF; Teh BS; Chintagumpala M
Cancer; 2013 Jul; 119(14):2654-9. PubMed ID: 23633429
[TBL] [Abstract][Full Text] [Related]
6. Effect of Temozolomide Combined with Intensity Modulated Radiation Therapy on Serum Factor, Immune Function and Clinical Efficacy in Postoperative Glioma Patients.
Yuan J; Liu J; Fan R; Liu Z
Radiat Res; 2023 Sep; 200(3):289-295. PubMed ID: 37797165
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of intraperitoneal bevacizumab combined with hyperthermic intraperitoneal chemotherapy in the treatment of patients with ovarian cancer and peritoneal effusion and the effect on serum lncRNA H19 and VEGF levels.
Zhang M; Bao Y; Zhang H; Li D; Mei X; Cheng X
J Obstet Gynaecol; 2023 Dec; 43(1):2204940. PubMed ID: 37186893
[TBL] [Abstract][Full Text] [Related]
8. A predictive value of von Willebrand factor for early response to Bevacizumab therapy in recurrent glioma.
Pace A; Mandoj C; Antenucci A; Villani V; Sperduti I; Casini B; Carosi M; Fabi A; Vidiri A; Koudriavtseva T; Conti L
J Neurooncol; 2018 Jul; 138(3):527-535. PubMed ID: 29594657
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bevacizumab combined with temozolomide in the treatment of recurrent malignant gliomas and its influence on serum tumor markers.
Lei J; Zhou Z
Am J Transl Res; 2021; 13(12):13886-13893. PubMed ID: 35035729
[TBL] [Abstract][Full Text] [Related]
10. Effect of comfort nursing on postoperative recovery and life quality of patients undergoing thoracic surgery.
Zhang B; Yang L; Ji X
Am J Transl Res; 2023; 15(12):6797-6804. PubMed ID: 38186997
[TBL] [Abstract][Full Text] [Related]
11. Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas.
Dhawan S; Patil CG; Chen C; Venteicher AS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD009229. PubMed ID: 31958162
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO).
Gil MJ; de Las Peñas R; Reynés G; Balañá C; Peréz-Segura P; García-Velasco A; Mesia C; Gallego O; Fernández-Chacón C; Martínez-García M; Herrero A; Andrés R; Benavides M; Quintanar T; Pérez-Martin X
Anticancer Drugs; 2012 Jul; 23(6):659-65. PubMed ID: 22634799
[TBL] [Abstract][Full Text] [Related]
14. Surgery for Recurrent High-Grade Glioma After Treatment with Bevacizumab.
Blumenthal DT; Kanner AA; Aizenstein O; Cagnano E; Greenberg A; Hershkovitz D; Ram Z; Bokstein F
World Neurosurg; 2018 Feb; 110():e727-e737. PubMed ID: 29183864
[TBL] [Abstract][Full Text] [Related]
15. Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.
Pinnix CC; Fontanilla HP; Hayes-Jordan A; Subbiah V; Bilton SD; Chang EL; Grosshans DR; McAleer MF; Sulman EP; Woo SY; Anderson P; Green HL; Mahajan A
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):317-26. PubMed ID: 22104361
[TBL] [Abstract][Full Text] [Related]
16. Retrospective efficacy analysis of olaparib combined with bevacizumab in the treatment of advanced colorectal cancer.
Jiang YL; Fu XY; Yin ZH
World J Gastrointest Surg; 2023 May; 15(5):906-916. PubMed ID: 37342840
[TBL] [Abstract][Full Text] [Related]
17. [Study on the value of prothrombin time for predicting the severity and prognosis of septic patients].
Bai H; Shen L; Jing L; Liu W; Sun Z; Tang N
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jul; 34(7):682-688. PubMed ID: 36100403
[TBL] [Abstract][Full Text] [Related]
18. Rescue bevacizumab following symptomatic pseudoprogression of a tectal glioma post-radiotherapy: a case report and review of the literature.
Nguyen TK; Perry J; Sundaram ANE; Detsky J; Maralani PJ; Calabrese E; Das S; Sahgal A
J Neurooncol; 2019 Jul; 143(3):475-481. PubMed ID: 31054097
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment*.
Yonezawa H; Ohno M; Igaki H; Miyakita Y; Takahashi M; Tamura Y; Shima S; Matsushita Y; Ichimura K; Narita Y
Jpn J Clin Oncol; 2021 Jul; 51(7):1028-1035. PubMed ID: 33959771
[TBL] [Abstract][Full Text] [Related]
20. NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer.
Viswanathan AN; Moughan J; Miller BE; Xiao Y; Jhingran A; Portelance L; Bosch WR; Matulonis UA; Horowitz NS; Mannel RS; Souhami L; Erickson BA; Winter KA; Small W; Gaffney DK
Cancer; 2015 Jul; 121(13):2156-63. PubMed ID: 25847373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
